Furthermore, Hou et al. [33] showed that selective serotonin reuptake inhibitor treatment for 12 weeks significantly reduced both baseline anxiety levels and pro-inflammatory cytokines, including IL-8, in patients with GAD. Here, CXCL8 is linked to generalized anxiety disorder.